Clinical Trials Logo

Clinical Trial Summary

Hypovitaminosis D is common in the adult population, it affects at least 1 billion people worldwide, and in particular 80% of the French population according to the National Institute for Public Health Surveillance. Hypovitaminosis D is accompanied or complicated by deleterious health manifestations such as bone, immune and cancer diseases, neuromuscular disorders and a propensity to fall, for example. Hypovitaminosis D has also been associated with more complicated care pathways (increase in the severity of the reason for hospitalization, length of hospitalization, risk of in-hospital death). Prevention of these clinical events depends on correcting vitamin D status. In sick, dependent or fragile adults, natural intakes are generally insufficient. It is indeed accepted that hypovitaminosis D may not be treated effectively by dietary measures or by simple exposure to the sun in French latitudes. Drug supplementation is therefore necessary, with the objective of achieving a target concentration of circulating 25-hydroxyvitamin D (25 (OH) D) of 75 nmol / L (30 ng / mL) in this population. Vitamin D supplementation, when properly conducted, corrects hypovitaminosis D, and has been associated with improved prognosis, especially life-saving, in therapeutic trials versus placebo. Such results lead the investigators to suggest that the identification and correction of hypovitaminosis D in hospitalized patients could represent a simple, effective and inexpensive strategy for improving hospital care pathways. In this perspective, the first step is to determine the prevalence, severity and clinical profile of hospitalized patients with hypovitaminosis D, as well as their course of care. To the investigators knowledge, there are no large-scale studies based on real-life data on this subject.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05214040
Study type Observational
Source University Hospital, Angers
Contact Cédric ANNWEILER, MD,PhD
Phone 02 41 35 47 25
Email cedric.annweiler@chu-angers.fr
Status Not yet recruiting
Phase
Start date September 2022
Completion date September 2026

See also
  Status Clinical Trial Phase
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT02802449 - To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans N/A
Recruiting NCT00992797 - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity Phase 2
Completed NCT00960232 - Vitamin D, Blood Pressure, Lipids, Infection and Depression Phase 3
Completed NCT02543671 - Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency N/A
Completed NCT01240213 - Vitamin D, Diet and Activity Study N/A
Completed NCT01793402 - Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants N/A
Completed NCT00887666 - Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure N/A
Completed NCT05425914 - Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level Phase 3
Not yet recruiting NCT04829487 - The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D N/A
Completed NCT05372224 - Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis N/A
Completed NCT02101151 - Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE) N/A
Completed NCT00695474 - Vitamin D and Type 2 Diabetes - a Cross Sectional Study N/A
Completed NCT02434380 - Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes Phase 3
Completed NCT02534714 - Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
Withdrawn NCT00944606 - Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children N/A
Recruiting NCT06138249 - Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels N/A
Completed NCT05346419 - Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients N/A
Completed NCT03381378 - Vitamin D and Hand Grip Strength at 5 Years in Odense Child Cohort N/A
Completed NCT02452762 - Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial Phase 2